Next Generation Therapeutic Classes
Jennerex is exploring several new cancer product platforms via newly engineered targeted oncolytic viruses. By selecting the optimal strain and species of virus for the backbone, enhancing the selectivity and potency through multiple targeted mutations, and creating enhancements through the addition of relevant transgenes, Jennerex is constructing novel oncolytic viruses that have unique features and are targeted for particular cancer types.
